Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osnat Melamed

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 4, 2015
Glutamatergic synapse protein composition of wild-type mice is sensitive to in utero MTHFR genotype and the timing of neonatal vigabatrin exposureChava Zuckerman, Elinor Blumkin, Osnat Melamed, et al.
Journal of Adult Development|February 15, 2023
The Role of Personality Risk and Protective Factors in Living with Covid-19: A Longitudinal StudyShmuel Shulman, Jacob Stein, Osnat Melamed, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 15, 2011
Gender-specific effect of Mthfr genotype and neonatal vigabatrin interaction on synaptic proteins in mouse cortexElinor Blumkin, Tamar Levav-Rabkin, Osnat Melamed, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 14, 2022
Effects of COVID-19-Related Disruptions on Service Use in a Large Smoking Cessation ProgramScott Veldhuizen, Newsha Mahinpey, Laurie Zawertailo, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 10, 2023
Outcomes Among People With Schizophrenia Participating in General-Population Smoking Cessation Treatment: An Observational StudyScott Veldhuizen, Anjali Behal, Laurie Zawertailo, et al.
Brain Stimulation|July 5, 2023
Augmenting varenicline treatment with transcranial direct current stimulation (tDCS) increases smoking abstinence rates at end of treatmentHelena Zhang, Tarek K Rajji, Peter Selby, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 1, 2022
Disruptions in Primary Care among People with Schizophrenia in Ontario, Canada, During the COVID-19 PandemicEllen Stephenson, Abban Yusuf, Jessica Gronsbell, et al.
PLOS Mental Health|February 9, 2026
Developing standards for virtual delivery of mental health services in Canadian primary care: A qualitative study and modified Delphi processAbban Yusuf, Ginetta Salvalaggio, Osnat Melamed, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 2010
A sensitive period of mice inhibitory system to neonatal GABA enhancement by vigabatrin is brain region dependentTamar Levav-Rabkin, Osnat Melamed, Gerard Clarke, et al.
Neuropharmacology|January 28, 2014
Long-lasting glutamatergic modulation induced by neonatal GABA enhancement in miceOsnat Melamed, Tamar Levav-Rabkin, Chava Zukerman, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 4, 2015
Glutamatergic synapse protein composition of wild-type mice is sensitive to in utero MTHFR genotype and the timing of neonatal vigabatrin exposureChava Zuckerman, Elinor Blumkin, Osnat Melamed, et al.
Journal of Adult Development|February 15, 2023
The Role of Personality Risk and Protective Factors in Living with Covid-19: A Longitudinal StudyShmuel Shulman, Jacob Stein, Osnat Melamed, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 15, 2011
Gender-specific effect of Mthfr genotype and neonatal vigabatrin interaction on synaptic proteins in mouse cortexElinor Blumkin, Tamar Levav-Rabkin, Osnat Melamed, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 14, 2022
Effects of COVID-19-Related Disruptions on Service Use in a Large Smoking Cessation ProgramScott Veldhuizen, Newsha Mahinpey, Laurie Zawertailo, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 10, 2023
Outcomes Among People With Schizophrenia Participating in General-Population Smoking Cessation Treatment: An Observational StudyScott Veldhuizen, Anjali Behal, Laurie Zawertailo, et al.
Brain Stimulation|July 5, 2023
Augmenting varenicline treatment with transcranial direct current stimulation (tDCS) increases smoking abstinence rates at end of treatmentHelena Zhang, Tarek K Rajji, Peter Selby, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 1, 2022
Disruptions in Primary Care among People with Schizophrenia in Ontario, Canada, During the COVID-19 PandemicEllen Stephenson, Abban Yusuf, Jessica Gronsbell, et al.
PLOS Mental Health|February 9, 2026
Developing standards for virtual delivery of mental health services in Canadian primary care: A qualitative study and modified Delphi processAbban Yusuf, Ginetta Salvalaggio, Osnat Melamed, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 2010
A sensitive period of mice inhibitory system to neonatal GABA enhancement by vigabatrin is brain region dependentTamar Levav-Rabkin, Osnat Melamed, Gerard Clarke, et al.
Neuropharmacology|January 28, 2014
Long-lasting glutamatergic modulation induced by neonatal GABA enhancement in miceOsnat Melamed, Tamar Levav-Rabkin, Chava Zukerman, et al.
Pageof 2